All
Chinese transplant surgery ups technical ante
June 1st 2006Dermatology Times was able to secure an exclusive interview with Professor Guo Shuzhong, the Chinese surgeon who performed the world's second partial face transplant. At press time, no other U.S. media was able to arrange an interview because of tight Chinese government regulations. Working with our sister publication, Cosmetic Surgery Times China, Senior Staff Correspondent John Jesitus sat in, via conference call, with Dr. Guo, as he explained the circumstances that led him to perform the intricate surgery on a 30-year-old farmer mauled by a bear. The patient's injuries were so severe he had become a social outcast, going out in public only when necessary.
Legal issues complicate cosmetic laser treatments
June 1st 2006Common legal issues facing physicians who perform cosmetic laser treatments include medical malpractice, as well as issues related to physician extenders and the Health Insurance Portability and Accountability Act (HIPAA), an expert says.
Cancer & the skin Managing the cutaneous side effects of cancertreatments
May 1st 2006National report - Chemotherapy and radiation can createunwanted results ranging from hair loss to pigment problems.However, an expert tells Dermatology Times that with some newbiologically targeted cancer therapies, skin-related side effectsseem to provide a barometer of these treatments' effectiveness.
More than lip service: Lower face options minimize downtime
May 1st 2006National report - For treating the lips and lower face,experts tell Dermatology Times that options including fillers,botulinum toxin injections and newer resurfacing technologies candeliver excellent cosmetic results usually with little or nodowntime.
Soft-tissue augmentation need not be a bruising experience
May 1st 2006National report - While soft-tissue fillers offer the uniquebenefit of providing fast correction for busy patients who don'twant to have the down-time for a face-lift, bruising can throw amonkey wrench into the best-laid plans for stellar patientsatisfaction.
Microbicides take center stage among prospects for HIV prevention
May 1st 2006London - Intravaginal microbicides currently represent themost promising strategy for allowing women to protect themselvesagainst HIV transmission, according to Jonathan F. Weber, M.D., whospoke at the Annual Meeting of the European Academy of Dermatologyand Venereology.